Target intelligence / Profile preview

Ribosomal protein L36a pseudogene 26 (RPL36AP26)

Target
RPL36AP26
Molecular classification
Other (Pseudogene)
01

Overview

Ribosomal protein L36a pseudogene 26 (RPL36AP26) is a human processed pseudogene derived from the ribosomal protein L36a gene family. It is mapped to the human genome and retains sequence similarity to the parent ribosomal protein gene but does not encode a functional protein product. Like other processed pseudogenes of ribosomal proteins, it has no known translational, regulatory, or disease-related function and is not considered a therapeutic target[5][6][7][8]. The functional counterpart is ribosomal protein L36a (RPL36A), which is part of the ribosomal large (60S) subunit and plays a role in protein synthesis in the cell[1][2][3]. There are numerous processed pseudogenes derived from RPL36A scattered throughout the genome[1][3], but these, including RPL36AP26, are non-coding[5][7]. The gene symbol and synonyms such as "RPL36A_8_787" are alternate database designations for this pseudogene[6]. If you are seeking a protein-coding or therapeutically relevant ribosomal subunit, the correct target would be "Ribosomal protein L36a" (RPL36A), not RPL36AP26[1][2][3].

Other names
RPL36A_8_787RPL36AP26[6]
02

Mechanism of action

None

03

Biological functions

None (as a pseudogene, it does not encode a functional product)[5][7]
04

Disease associations

None directly; no established roles in disease as a pseudogene

Beyond the preview

Go deeper on Ribosomal protein L36a pseudogene 26 (RPL36AP26).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ribosomal protein L36a pseudogene 26 (RPL36AP26).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call